Words by GOLD newsdesk
Pfizer and Moderna have both recently announced the recruitment of new Chief Financial Officers (CFOs).
Pfizer, based in New York, has announced that David Denton will take over as CFO on 2 May, ending his time as Finance Chief for the home improvement retailer Lowe’s. He will also take up the position of Executive Vice President.
Commenting on the appointment, Albert Bourla, Chairman and Chief Executive Officer, Pfizer, said: “Dave brings with him deep financial experience, a track record of achievement and true insights into today’s healthcare system. For these reasons, he is the perfect leader to take the helm of our talented finance organization and deliver a comprehensive strategic financial vision that will help drive Pfizer’s future growth and success.”
Meanwhile, for Massachusetts-based Moderna's new CFO, Jorge Gomez, will take on the new position on 9 May, additionally taking a seat on the company's Executive Committee. Gomez previously held CFO position at dental-supply company, Dentsply Sirona.
"As we grow and scale the company globally, Jorge's experience leading the financial functions of multinational healthcare companies will be an asset to our team," said Stéphane Bancel, Chief Executive Officer, Moderna. "Jorge's passion for sustainability and ESG aligns closely with Moderna's vision to make corporate responsibility a critical part of who we are and what we do. I look forward to working with Jorge as we continue to deliver on our strategic priorities to ultimately impact human health with mRNA medicines."
COVID-19 vaccine sales have enhanced both companies’ financial performance and the vaccine makers are exploring ways to deploy the recently generated funds and address major healthcare challenges around the world.